Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Chloride SCHEMBL3870935 | 0.94 | PGR (0.37) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL5965042 | 0.83 | FDPS (0.36) | TDP1FDPS | |
| SCHEMBL127513 | 0.82 | PGR (0.47) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL2828450 | 0.80 | MMP1 (0.36) | TDP1TSHR | |
| Chloromethane SCHEMBL4598656 | 0.78 | PGR (0.44) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL1275887 | 0.78 | MEN1 (0.32) | TDP1 | |
| Ethyl Chloride SCHEMBL3884054 | 0.77 | PGR (0.43) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL888048 | 0.77 | TDP1 (0.33) | TDP1FDPS | |
| SCHEMBL1432484 | 0.77 | PGR (0.45) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL27722580 | 0.77 | PGR (0.45) | PGRADRA2AADRA2BHTR2AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3660061-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2023-06-21 | — | — | EP | claimed |
| EP-3245236-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2020-09-23 | — | — | EP | claimed |
| EP-2351779-B1 | Microspheres and method of making the microspheres | BIOSPHERE MEDICAL INC (US) | 2019-04-24 | — | — | EP | claimed |
| US-10166527-B2 | Surface modification of porous base supports | MERCK PATENT GMBH (DE) | 2019-01-01 | — | — | US | claimed |
| US-10022469-B2 | Microspheres useful for therapeutic vascular embolization | BioSphere Medical, SA (US) | 2018-07-17 | — | — | US | claimed |
| EP-2310104-B1 | MIXED GRAFT POLYMERS FOR ION EXCHANGE CHROMATOGRAPHY | MERCK PATENT GMBH (DE) | 2017-10-18 | — | — | EP | claimed |
| US-20160361458-A1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR EMBOLIZATION | BIOSPHERE MEDICAL SA (FR) | 2016-12-15 | — | — | US | claimed |
| US-9439861-B2 | Microspheres useful for therapeutic vascular embolization | BioSphere Medical, SA (US) | 2016-09-13 | — | — | US | claimed |
| US-9295648-B2 | Injectable microspheres for dermal augmentation and tissue bulking | BIOSPHERE MEDICAL, INC. (US) | 2016-03-29 | — | — | US | claimed |
| US-20150298097-A1 | SURFACE MODIFICATION OF POROUS BASE SUPPORTS | MERCK PATENT GMBH (DE) | 2015-10-22 | — | — | US | claimed |
| US-5075371-A | COMPOSITE POLYMERS AND THEIR PREPARATION WHICH ARE USEFUL IN LIQUID CHROMATOGRAPHY | I.B.F. (FR) | 1991-12-24 | — | — | US | claimed |
| US-5053135-A | COMPOSITE POLYMERS, THEIR PREPARATION AND THEIR USE IN LIQUID CHROMATOGRAPHY | I.B.F. (FR) | 1991-10-01 | — | — | US | claimed |
| US-5021167-A | Oil in water emulsion | NALCO CHEMICAL COMPANY (US) | 1991-06-04 | — | — | US | claimed |
| EP-0373626-A2 | Cell culture carriers | MITSUBISHI KASEI CORPORATION (JP) | 1990-06-20 | — | — | EP | claimed |
| US-4931191-A | Method for separating solids from water using amine containing polymers | NALCO CHEMICAL COMPANY (US) | 1990-06-05 | — | — | US | claimed |
| EP-0331528-A1 | Antimicrobial ethylene copolymers and compositions thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-09-06 | — | — | EP | claimed |
| US-4842987-A | Photosensitive element for producing printing plates or resist images | BASF AKTIENGESELLSCHAFT (DE) | 1989-06-27 | — | — | US | claimed |
| US-4699951-A | MIXTURE OF VINYL HOMOPOLYMER AND, ACRYLAMIDE COPOLYMERIZED WITH VINYL POLYMER | NALCO CHEMICAL COMPANY (US) | 1987-10-13 | — | — | US | claimed |
| US-4020192-A | AMINO ALKYL AMIDE ACRYLIC POLYMER | FUJI XEROX CO., LTD. (JA) | 1977-04-26 | — | — | US | claimed |
| US-4013513-A | Ion exchange chromatographic isoenzyme separation and isolation | E-C APPARATUS CORPORATION (US) | 1977-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10022469-B2 | Microspheres useful for therapeutic vascular embolization | CD68, FGB, MB | PGR 2202/4885ADRA2A 2473/4885ADRA2B 2303/4885 |
| US-20160361458-A1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR EMBOLIZATION | CD68, FGB, MB | PGR 2202/4885ADRA2A 2473/4885ADRA2B 2303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.